1. Home
  2. MLP vs TRDA Comparison

MLP vs TRDA Comparison

Compare MLP & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

N/A

Current Price

$15.90

Market Cap

341.9M

Sector

Finance

ML Signal

N/A

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$6.82

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLP
TRDA
Founded
1909
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.9M
275.3M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
MLP
TRDA
Price
$15.90
$6.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
11.7K
251.4K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,457,000.00
$25,421,000.00
Revenue This Year
N/A
$39.97
Revenue Next Year
N/A
$50.80
P/E Ratio
N/A
N/A
Revenue Growth
68.24
N/A
52 Week Low
$13.84
$5.02
52 Week High
$20.34
$16.45

Technical Indicators

Market Signals
Indicator
MLP
TRDA
Relative Strength Index (RSI) 46.12 45.26
Support Level $15.07 $5.71
Resistance Level $16.46 $7.89
Average True Range (ATR) 0.57 0.45
MACD 0.05 -0.06
Stochastic Oscillator 41.95 32.62

Price Performance

Historical Comparison
MLP
TRDA

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: